--- title: Sanofi Is Now the Third Insulin Producer to Slash Prices description: The pharmaceutical company will reduce the U.S. list price of Lantus, its most-prescribed insulin, by 78%, and Apidra by 70%. canonical: https://time.com/6264077/sanofi-insulin-price-cuts/ author: TIME article:opinion: false article:content_tier: free article:published_time: 2023-03-17T13:27:43.000Z article:modified_time: 2026-02-24T15:36:00.050Z article:section: Health og:title: Sanofi Is Now the Third Insulin Producer to Slash Prices og:description: The pharmaceutical company will reduce the U.S. list price of Lantus, its most-prescribed insulin, by 78% og:url: https://time.com/6264077/sanofi-insulin-price-cuts/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt3bc97b7827cad35b/698a3b3dcabb1db5cbe513a8/sanofi-insulin-lantus.jpg?branch=production&width=3840&quality=75&auto=webp&crop=16:9 og:image:width: 1200 og:image:height: 675 og:image:alt: sanofi-insulin-lantus og:type: article twitter:card: summary_large_image twitter:title: Sanofi Is Now the Third Insulin Producer to Slash Prices twitter:description: The pharmaceutical company will reduce the U.S. list price of Lantus, its most-prescribed insulin, by 78% twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt3bc97b7827cad35b/698a3b3dcabb1db5cbe513a8/sanofi-insulin-lantus.jpg?branch=production&width=3840&quality=75&auto=webp&crop=16:9 ---  # Sanofi Is Now the Third Insulin Producer to Slash Prices by [Ilena Peng/Bloomberg](/author/bloomberg/) ## Ilena Peng/Bloomberg Mar 17, 2023 1:27 PM CUT  Sanofi Lantus brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019\. Makers of top-selling insulin products will continue to bear the brunt of Congress' drug-pricing efforts in 2019 as diabetes remains a source of frustration to policy makers in both parties. Photographer: Alex Flynn/Bloomberg via Getty Images Sanofi Lantus brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019\. Makers of top-selling insulin products will continue to bear the brunt of Congress' drug-pricing efforts in 2019 as diabetes remains a source of frustration to policy makers in both parties. Photographer: Alex Flynn/Bloomberg via Getty ImagesAlex Flynn/Bloomberg—Getty Images by [Ilena Peng/Bloomberg](/author/bloomberg/) ## Ilena Peng/Bloomberg Mar 17, 2023 1:27 PM CUT Sanofi will cut the U.S. list price of two of its insulins, making it the third major producer of the diabetes medicine to recently slash prices. French pharmaceutical maker Sanofi will reduce the U.S. list price of Lantus, its most-prescribed insulin, by 78%, according to a [statement](https://www.sanofi.com/en/media-room/press-releases/2023/2023-03-16-20-06-43-2629188 "undefined") Thursday. The company will also reduce the list price of Apidra by 70%. “We are pleased to see others join our efforts to help patients as we now accelerate the transformation of the U.S. insulin market,” said Olivier Bogillot, the head of U.S. general medicines. “Our decision to cut the list price of our lead insulin needs to be coupled with broader change to the overall system to actually drive savings for patients at the pharmacy counter.” Read More: [_Insulin Isn’t the Only High Cost for People With Diabetes_](https://time.com/6260840/insulin-price-cap-eli-lilly-diabetes-care/ "undefined") The company will also cap out-of-pocket costs for Lantus at $35\. The moves, which take effect in 2024, mirror the steps of rivals Eli Lilly & Co and Novo Nordisk A/S. These price reductions from the three big insulin players follow increased pressure from lawmakers and advocates, who have raised concerns about affordability for patients. The companies could also stand to see financial benefits next year as a result of the price cuts, due to an upcoming change to how much manufacturers could have to pay Medicaid in rebates. Novo announced Tuesday that it would cut list prices for NovoLog and NovoLog Mix 70/30 by 75%. The company is also reducing prices for Novolin and Levemir, as well as several unbranded insulins. Lilly, the first to announce price changes earlier this month, will lower Humalog and Humulin prices by 70% and cap out-of-pocket costs at $35. ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/6264077/sanofi-insulin-price-cuts/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/6264077/sanofi-insulin-price-cuts/"},"headline":"Sanofi Is Now the Third Insulin Producer to Slash Prices","datePublished":"2023-03-17T13:27:43.000Z","dateModified":"2026-02-24T15:36:00.050Z","description":"The pharmaceutical company will reduce the U.S. list price of Lantus, its most-prescribed insulin, by 78%.","url":"https://time.com/6264077/sanofi-insulin-price-cuts/","keywords":["Drugs","wire","healthscienceclimate","bloomberg wire"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt3bc97b7827cad35b/698a3b3dcabb1db5cbe513a8/sanofi-insulin-lantus.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Ilena Peng/Bloomberg"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt3bc97b7827cad35b/698a3b3dcabb1db5cbe513a8/sanofi-insulin-lantus.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"sanofi-insulin-lantus","caption":"sanofi-insulin-lantus","creditText":"Alex Flynn/Bloomberg—Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"/tag/drugs/","name":"Drugs"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/6264077/sanofi-insulin-price-cuts/","name":"Sanofi Is Now the Third Insulin Producer to Slash Prices"}}]}] ```